This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsKhosla Ventures Acquisition (KVSA) 주식 개요Khosla Ventures Acquisition Co. does not have significant operations. 자세히 보기KVSA 펀더멘털 분석스노우플레이크 점수가치 평가4/6미래 성장0/6과거 실적1/6재무 건전성1/6배당0/6강점공정 가치 추정치보다 낮은 97.8% 에서 거래올해부터 흑자전환위험 분석수익이 USD$1m 미만입니다($0)마이너스 주주 지분재무 결과에 영향을 미치는 대규모 일회성 항목의미 있는 시가총액이 없습니다($74M)+ 위험 2건 추가모든 위험 점검 보기KVSA Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW493,086 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG493,086 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$10.74해당 없음내재 할인율Est. Revenue$PastFuture-1m5m2016201920222025202620282031Revenue US$1.0Earnings US$0AdvancedSet Fair ValueView all narrativesKhosla Ventures Acquisition Co. 경쟁사Crescera Capital AcquisitionSymbol: OTCPK:CREE.FMarket cap: US$75.0mAimfinity Investment ISymbol: OTCPK:AIMU.FMarket cap: US$6.9mHeritage GlobalSymbol: NasdaqCM:HGBLMarket cap: US$43.4mHome Plate AcquisitionSymbol: NasdaqCM:HPLTMarket cap: US$76.5m가격 이력 및 성과Khosla Ventures Acquisition 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$10.7452주 최고가US$11.2252주 최저가US$9.94베타0.0721개월 변동1.70%3개월 변동0.94%1년 변동7.94%3년 변동n/a5년 변동n/aIPO 이후 변동4.78%최근 뉴스 및 업데이트공고 • Dec 22Khosla Ventures Acquisition Co. Files Form 15Khosla Ventures Acquisition Co. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Class A Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Class A Common Stock was $0.0001 per share.공고 • Dec 13Khosla Ventures Acquisition Co.(NasdaqCM:KVSA) dropped from NASDAQ Composite IndexKhosla Ventures Acquisition Co. has been dropped from NASDAQ Composite Index .공고 • Aug 25Khosla Ventures Acquisition Receives Non-Compliance Letter from NasdaqOn August 18, 2023, Khosla Ventures Acquisition Co. (the Company") received a letter (the Nasdaq Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company's listed securities maintain a minimum Market Value of Listed Securities (MVLS") of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. Anytime during the compliance period described above, the company's MVLS must close at $35 million or more for a minimum of ten consecutive business days, at which point Nasdaq will provide the Company with written confirmation of compliance. The Company is working to comply with Nasdaq's MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$73.0m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.0m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$73.0m market cap).공고 • Apr 03Khosla Ventures Acquisition Co. announced delayed annual 10-K filingOn 04/01/2022, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공고 • Feb 15Khosla Ventures Acquisition Co. Announces Resignation of Jagdeep Singh from the BoardOn February 10, 2022 Jagdeep Singh notified the Board of Directors of Khosla Ventures Acquisition Co. of his resignation from the Board and all committees thereof, effective immediately.더 많은 업데이트 보기Recent updates공고 • Dec 22Khosla Ventures Acquisition Co. Files Form 15Khosla Ventures Acquisition Co. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Class A Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Class A Common Stock was $0.0001 per share.공고 • Dec 13Khosla Ventures Acquisition Co.(NasdaqCM:KVSA) dropped from NASDAQ Composite IndexKhosla Ventures Acquisition Co. has been dropped from NASDAQ Composite Index .공고 • Aug 25Khosla Ventures Acquisition Receives Non-Compliance Letter from NasdaqOn August 18, 2023, Khosla Ventures Acquisition Co. (the Company") received a letter (the Nasdaq Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company's listed securities maintain a minimum Market Value of Listed Securities (MVLS") of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. Anytime during the compliance period described above, the company's MVLS must close at $35 million or more for a minimum of ten consecutive business days, at which point Nasdaq will provide the Company with written confirmation of compliance. The Company is working to comply with Nasdaq's MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$73.0m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.0m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$73.0m market cap).공고 • Apr 03Khosla Ventures Acquisition Co. announced delayed annual 10-K filingOn 04/01/2022, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공고 • Feb 15Khosla Ventures Acquisition Co. Announces Resignation of Jagdeep Singh from the BoardOn February 10, 2022 Jagdeep Singh notified the Board of Directors of Khosla Ventures Acquisition Co. of his resignation from the Board and all committees thereof, effective immediately.공고 • Sep 01Khosla Ventures Acquisition Co. Receives Expected Notice from Nasdaq Regarding Delayed Quarterly ReportKhosla Ventures Acquisition Co. announced August 31, 2021 that, on August 25, 2021, it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market. As previously disclosed in the Form 12b-25 filed on August 16, 2021 by the Company with the SEC, the Company was unable to file the Form 10-Q by the required due date of August 16, 2021. The Company intends to file the Form 10-Q with the SEC as soon as practicable.공고 • Aug 17Khosla Ventures Acquisition Co. announced delayed 10-Q filingOn 08/16/2021, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공고 • Jun 10Valo Health, LLC entered into an agreement to acquire Khosla Ventures Acquisition Co. (NasdaqCM:KVSA) from Khosla Ventures SPAC Sponsor LLC and others in a reverse merger transaction for $2.3 billion.Valo Health, LLC entered into an agreement to acquire Khosla Ventures Acquisition Co. (NasdaqCM:KVSA) from Khosla Ventures SPAC Sponsor LLC and others in a reverse merger transaction for $2.3 billion on June 9, 2021. Under the terms of the agreement, Valo Health will get 225 million Class A common stock of Khosla Ventures. In addition, on June 9, 2021, concurrently with the execution of the merger agreement, Khosla Ventures entered into subscription agreements pursuant to which investors have collectively subscribed for approximately 16.85 million shares of Khosla Ventures common stock for an aggregate purchase price equal to $168.5 million. Post the transaction, existing Valo rollover equity would be 80%, subscription investors will hold 8%, Khosla Ventures public shares will constitute 10%, and Khosla Ventures sponsor shares will constitute 2%. Upon closing, Khosla Ventures Acquisition will immediately be renamed Valo Health, Inc. Samir Kaul, Founding Partner and Managing Director at Khosla Ventures to join Valo’s Board of Directors following the completion of the business combination. The Board of Directors Khosla Ventures Acquisition has unanimously approved the transaction and Boards of Directors of Valo has approved the transaction. The transaction is subject to approval of the stockholders of Khosla Ventures and equity holders of Valo; effectiveness of the proxy statement / registration statement on Form S-4 to filed in connection with transaction; expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act; receipt of approval for listing on the Nasdaq Stock Market the shares of Khosla Ventures to be issued in connection with the merger; Khosla Ventures have at least $5,000,001 of net tangible assets upon closing; and he completion of the Pre-Closing Restructuring no later than one business day prior to the closing. The closing of this transaction is expected to occur in the third quarter of 2021. Jim Morrone and Luke J. Bergstrom of Latham & Watkins LLP acted as legal advisors to Khosla Ventures. Joseph C. Theis and Stuart M. Cable of Goodwin Procter LLP acted as legal advisors, and, J.P. Morgan Securities LLC acted as financial advisor to Valo. J.P. Morgan Securities LLC acted as Khosla Ventures' sole placement agent for the subscription agreement. Cooley LLP is acting as legal counsel to the placement agent.공고 • May 19Khosla Ventures Acquisition Co. announced delayed 10-Q filingOn 05/18/2021, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.주주 수익률KVSAUS Capital MarketsUS 시장7D0.09%0.1%0.1%1Y7.9%2.8%20.3%전체 주주 수익률 보기수익률 대 산업: KVSA은 지난 1년 동안 2.8%의 수익을 기록한 US Capital Markets 산업보다 저조한 성과를 냈습니다.수익률 대 시장: KVSA은 지난 1년 동안 20.3%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is KVSA's price volatile compared to industry and market?KVSA volatilityKVSA Average Weekly Movement1.5%Capital Markets Industry Average Movement3.9%Market Average Movement7.3%10% most volatile stocks in US Market16.7%10% least volatile stocks in US Market3.2%안정적인 주가: KVSA는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: KVSA의 주간 변동성(1%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트2021n/aSamir Kaulkhoslaventuresacquisitionco.com/kvsa더 보기Khosla Ventures Acquisition Co. 기초 지표 요약Khosla Ventures Acquisition의 순이익과 매출은 시가총액과 어떻게 비교됩니까?KVSA 기초 통계시가총액US$74.31m순이익 (TTM)US$5.39m매출 (TTM)n/a13.8x주가수익비율(P/E)0.0x주가매출비율(P/S)KVSA는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표KVSA 손익계산서 (TTM)매출US$0매출원가US$0총이익US$0기타 비용-US$5.39m순이익US$5.39m최근 보고된 실적Sep 30, 2023다음 실적 발표일해당 없음주당순이익(EPS)0.78총이익률0.00%순이익률0.00%부채/자본 비율-35.1%KVSA의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/12/13 05:43종가2023/12/11 00:00수익2023/09/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Khosla Ventures Acquisition Co.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공고 • Dec 22Khosla Ventures Acquisition Co. Files Form 15Khosla Ventures Acquisition Co. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Class A Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Class A Common Stock was $0.0001 per share.
공고 • Dec 13Khosla Ventures Acquisition Co.(NasdaqCM:KVSA) dropped from NASDAQ Composite IndexKhosla Ventures Acquisition Co. has been dropped from NASDAQ Composite Index .
공고 • Aug 25Khosla Ventures Acquisition Receives Non-Compliance Letter from NasdaqOn August 18, 2023, Khosla Ventures Acquisition Co. (the Company") received a letter (the Nasdaq Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company's listed securities maintain a minimum Market Value of Listed Securities (MVLS") of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. Anytime during the compliance period described above, the company's MVLS must close at $35 million or more for a minimum of ten consecutive business days, at which point Nasdaq will provide the Company with written confirmation of compliance. The Company is working to comply with Nasdaq's MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.
New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$73.0m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.0m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$73.0m market cap).
공고 • Apr 03Khosla Ventures Acquisition Co. announced delayed annual 10-K filingOn 04/01/2022, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공고 • Feb 15Khosla Ventures Acquisition Co. Announces Resignation of Jagdeep Singh from the BoardOn February 10, 2022 Jagdeep Singh notified the Board of Directors of Khosla Ventures Acquisition Co. of his resignation from the Board and all committees thereof, effective immediately.
공고 • Dec 22Khosla Ventures Acquisition Co. Files Form 15Khosla Ventures Acquisition Co. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Class A Common Stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Class A Common Stock was $0.0001 per share.
공고 • Dec 13Khosla Ventures Acquisition Co.(NasdaqCM:KVSA) dropped from NASDAQ Composite IndexKhosla Ventures Acquisition Co. has been dropped from NASDAQ Composite Index .
공고 • Aug 25Khosla Ventures Acquisition Receives Non-Compliance Letter from NasdaqOn August 18, 2023, Khosla Ventures Acquisition Co. (the Company") received a letter (the Nasdaq Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company's listed securities maintain a minimum Market Value of Listed Securities (MVLS") of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)(2), which compliance period will expire on February 14, 2024. Anytime during the compliance period described above, the company's MVLS must close at $35 million or more for a minimum of ten consecutive business days, at which point Nasdaq will provide the Company with written confirmation of compliance. The Company is working to comply with Nasdaq's MVLS requirements as set forth in the Nasdaq Listing Rule 5550(b)(2) within the compliance period provided by Nasdaq.
New Risk • Aug 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$73.0m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$7.0m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Market cap is less than US$100m (US$73.0m market cap).
공고 • Apr 03Khosla Ventures Acquisition Co. announced delayed annual 10-K filingOn 04/01/2022, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공고 • Feb 15Khosla Ventures Acquisition Co. Announces Resignation of Jagdeep Singh from the BoardOn February 10, 2022 Jagdeep Singh notified the Board of Directors of Khosla Ventures Acquisition Co. of his resignation from the Board and all committees thereof, effective immediately.
공고 • Sep 01Khosla Ventures Acquisition Co. Receives Expected Notice from Nasdaq Regarding Delayed Quarterly ReportKhosla Ventures Acquisition Co. announced August 31, 2021 that, on August 25, 2021, it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market. As previously disclosed in the Form 12b-25 filed on August 16, 2021 by the Company with the SEC, the Company was unable to file the Form 10-Q by the required due date of August 16, 2021. The Company intends to file the Form 10-Q with the SEC as soon as practicable.
공고 • Aug 17Khosla Ventures Acquisition Co. announced delayed 10-Q filingOn 08/16/2021, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공고 • Jun 10Valo Health, LLC entered into an agreement to acquire Khosla Ventures Acquisition Co. (NasdaqCM:KVSA) from Khosla Ventures SPAC Sponsor LLC and others in a reverse merger transaction for $2.3 billion.Valo Health, LLC entered into an agreement to acquire Khosla Ventures Acquisition Co. (NasdaqCM:KVSA) from Khosla Ventures SPAC Sponsor LLC and others in a reverse merger transaction for $2.3 billion on June 9, 2021. Under the terms of the agreement, Valo Health will get 225 million Class A common stock of Khosla Ventures. In addition, on June 9, 2021, concurrently with the execution of the merger agreement, Khosla Ventures entered into subscription agreements pursuant to which investors have collectively subscribed for approximately 16.85 million shares of Khosla Ventures common stock for an aggregate purchase price equal to $168.5 million. Post the transaction, existing Valo rollover equity would be 80%, subscription investors will hold 8%, Khosla Ventures public shares will constitute 10%, and Khosla Ventures sponsor shares will constitute 2%. Upon closing, Khosla Ventures Acquisition will immediately be renamed Valo Health, Inc. Samir Kaul, Founding Partner and Managing Director at Khosla Ventures to join Valo’s Board of Directors following the completion of the business combination. The Board of Directors Khosla Ventures Acquisition has unanimously approved the transaction and Boards of Directors of Valo has approved the transaction. The transaction is subject to approval of the stockholders of Khosla Ventures and equity holders of Valo; effectiveness of the proxy statement / registration statement on Form S-4 to filed in connection with transaction; expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act; receipt of approval for listing on the Nasdaq Stock Market the shares of Khosla Ventures to be issued in connection with the merger; Khosla Ventures have at least $5,000,001 of net tangible assets upon closing; and he completion of the Pre-Closing Restructuring no later than one business day prior to the closing. The closing of this transaction is expected to occur in the third quarter of 2021. Jim Morrone and Luke J. Bergstrom of Latham & Watkins LLP acted as legal advisors to Khosla Ventures. Joseph C. Theis and Stuart M. Cable of Goodwin Procter LLP acted as legal advisors, and, J.P. Morgan Securities LLC acted as financial advisor to Valo. J.P. Morgan Securities LLC acted as Khosla Ventures' sole placement agent for the subscription agreement. Cooley LLP is acting as legal counsel to the placement agent.
공고 • May 19Khosla Ventures Acquisition Co. announced delayed 10-Q filingOn 05/18/2021, Khosla Ventures Acquisition Co. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
